BioSpace News Archive

Alimera Sciences, Inc. (Nasdaq: ALIM) (Alimera), a global pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharmaceuticals for the treatment of retinal diseases, announces preliminary consolidated net revenue for the fourth quarter of 2020 in excess of $13.5 million and annual 2020 consolidated net revenue in excess of $50.5 million.

Petros Pharmaceuticals (Nasdaq: PTPI) today announces that its president and chief commercial officer Fady Boctor will present at NobleCon17 - Noble Capital Markets’ Seventeenth Annual Investor Conference on Wednesday, January 20, 2021 at 9:00 AM ET in Track 2. A high-definition, video webcast of the presentation will be available the following day on the Company’s website www.petrospharma.com, and as part of a complete catalog of presentations to

Applied Molecular Transport Inc. (Nasdaq: AMTI) (AMT), a clinical-stage biopharmaceutical company, today announced that it has appointed Douglas Rich as Chief Technical Officer.

AgBiome, a leader in developing innovative products from the Earth’s microbial communities, announced Dr. Marijn Dekkers as the company’s Chairman, effective January 1, 2021.

A senior secured term loan will support the further development of VERO Biotech’s GENOSYL® Delivery System, a proprietary tankless and portable delivery system for the administration of GENOSYL® (nitric oxide) gas, for inhalation

Sumitomo Dainippon Pharma Oncology, Inc., a developer of novel cancer therapeutics, today announced that the first patient has been dosed in a Phase 1/2 study evaluating the investigational agent TP-0184, an activin receptor-like kinase 2 (ALK2) and ALK5 inhibitor, for the treatment of anemia in adult patients with low or intermediate risk myelodysplastic syndromes (MDS).

A new study in Mayo Clinic Proceedings entitled “Aseptic Stethoscope Barriers Prevent C. difficile Transmission In Vitro"2 finds that aseptic disk covers from AseptiScope, available now commercially in the company’s flagship product, The DiskCover System™, completely blocked the growth of C. difficile on stethoscope diaphragms.

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced it has entered into a definitive agreement to acquire Mesa Biotech, Inc., a privately held molecular diagnostic company, for approximately $450 million in cash

Ace Vision Group, Inc, an emerging ophthalmic laser device company focused on bringing innovative touchless Eye Laser Therapy to patients suffering from age related vision loss, announced that it closed a Series A preferred stock round totaling $13.3M, which is $3.3M oversubscribed.

Immunexpress, Inc., a molecular diagnostic company focused on improving outcomes for suspected sepsis patients, today announced the publication of an abstract for a research snapshot presentation to be presented as part of the Society of Critical Care Medicine’s (SCCM) 50th Annual Critical Care Congress being held virtually Jan. 31 through Feb. 12, 2021.